PortViewPortView
Claritev logo

Claritev (CTEV) Stock Analysis

NYSEHealthcareMedical - Healthcare Information Services

$39.38+0.08%
1-year price historyRange $13.47 – $72.45
52-week range$39.38
$11.50$74.07

What Claritev does

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Key metrics

Market cap
$671.34M
P/E (TTM)
-2.32
EPS (TTM)
$-17.01
Beta
0.79
Dividend yield
0.00%
Revenue / share
$58.63
50-day avg
$31.63
200-day avg
$28.31
52-week high
$74.07
52-week low
$11.50
CEO
Travis S. Dalton

ETFs linked to CTEV

Broad-market and Healthcare sector ETFs an investor holding Claritev is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CTEV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CTEV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Claritev?
Claritev trades under the ticker CTEV on NYSE.
Which exchange is CTEV listed on?
CTEV is listed on NYSE.
What sector does Claritev operate in?
Claritev is classified in the Healthcare sector (Medical - Healthcare Information Services industry).
How can PortView help analyze CTEV in a portfolio?
PortView shows CTEV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.